114248-23-6Relevant articles and documents
A Bioorthogonal Chemical Reporter of Viral Infection
Neef, Anne B.,Pernot, Lucile,Schreier, Verena N.,Scapozza, Leonardo,Luedtke, Nathan W.
, p. 7911 - 7914 (2015)
Pathogen-selective labeling was achieved by using the novel gemcitabine metabolite analogue 2′-deoxy-2′,2′-difluoro-5-ethynyluridine (dF-EdU) and click chemistry. Cells infected with Herpes Simplex Virus-1 (HSV-1), but not uninfected cells, exhibit nuclear staining upon the addition of dF-EdU and a fluorescent azide. The incorporation of the dF-EdU into DNA depends on its phosphorylation by a herpes virus thymidine kinase (TK). Crystallographic analyses revealed how dF-EdU is well accommodated in the active site of HSV-1 TK, but steric clashes prevent dF-EdU from binding human TK. These results provide the first example of pathogen-enzyme-dependent incorporation and labeling of bioorthogonal functional groups in human cells.
Novel derivatives of nucleosides
-
Paragraph 0095-0097, (2017/12/27)
PURPOSE: A novel nucleoside derivative and a method for synthesizing the same are provided to ensure excellent bioavailability and to enable oral administration. CONSTITUTION: A novel nucleoside derivative is a compound of chemical formula 2. A method for preparing the compound of chemical formula 2 comprise a step of adding NaOMe or hydrogen ion to a compound of chemical formula 10. The compound of chemical formula 10 is prepared by adding LiN_3 to a compound of chemical formula 9.
SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF
-
Paragraph 0543; 0546, (2016/03/11)
Disclosed herein are nucleosides, nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a Filoviridae virus infection with one or more nucleosides and/or nucleotide analogs.